Parkinson's and blood pressure study with MRI
Part of Brain & nervous system, Heart & circulation clinical trials.
This study uses MRI to understand how blood pressure is controlled in people with Parkinson's disease who have orthostatic hypotension (a drop in blood pressure when standing). It may help find better treatments for this common symptom.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Parkinson's disease diagnosed by a movement disorder specialist.
- You are between 18 and 75 years old.
- You are taking medication for Parkinson's disease (like levodopa or dopamine agonists).
- You can live independently and follow the study schedule.
- You do not have certain health conditions like dementia, diabetes, or recent stroke/heart attack.
- You are able to have an MRI (no metal implants, claustrophobia, or allergy to the contrast agent).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adjusting the ratio of carbidopa and levodopa (medications used for Parkinson's) can help reduce dizziness or fainting from low blood pressure when standing up, in people with Multiple System Atrophy (Parkinsonian type) or Parkinson's disease.
This study measures how your blood pressure affects thinking skills and how blood flows in the brain in people with Parkinson’s. It may help researchers understand what blood-pressure changes could mean for cognition in Parkinson’s.
This trial tests a new intelligent diagnostic system to help diagnose orthostatic hypotension (a drop in blood pressure when standing up) in people with Parkinson's disease, multiple system atrophy, or diabetes. It uses a non-invasive ultrasound device (TCD) to monitor blood flow in the brain.
This early (Phase 1) study tests whether midodrine and droxidopa can improve blood-flow pooling in the belly in people with nerve problems that affect blood pressure when standing. It’s looking at safety and how the body responds, which may help reduce dizziness or fainting for some participants.
This Phase 2 study tests whether the medicines droxidopa and pyridostigmine can improve symptoms of orthostatic hypotension, which is low blood pressure when you stand up. It is designed for people whose low blood pressure is caused by problems with the nerves that control blood pressure.
This trial looks at how blood pressure and heart rate change when standing up or exercising in healthy people and in older adults with high blood pressure. It aims to understand how the body's automatic (autonomic) nervous system controls these functions.
Hear when a new Orthostatic Hypotension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.